Drug Search Results
More Filters [+]

Rimonabant

Alternative Names: rimonabant, sr141716
Latest Update: 2024-05-06
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: CB1 Antagonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | Chile | Colombia | European Medicines Agency | Germany | Hungary | India | Ireland | Italy | Peru | Portugal | Slovenia | Sweden | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Sanofi
Company Location: PARIS I0 75008
Company CEO: Paul Hudson
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Rimonabant

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Atherosclerosis|Obesity|Other|Overweight|Insulin Resistance|Inflammation|Cocaine-Related Disorders|Healthy Volunteers|Diabetes, Gestational|Alcoholism|Obesity, Abdominal|Dyslipidemia

Phase 3: Tobacco Use Disorder|Type 2 Diabetes|Fatty Liver, Alcoholic|Non-alcoholic Fatty Liver Disease|Obesity|Stroke|Prader-Willi Syndrome|Myocardial Infarction|Dyslipidemia|Overweight|Arteriosclerosis|Carotid Stenosis|Obesity, Abdominal|Smoking Cessation|Hepatitis, Alcoholic|Weight Gain|Coronary Artery Disease|Metabolic Syndrome X|Other|Weight Loss|Spinal Cord Injuries|Schizophrenia|Albuminuria|Atherosclerosis|Myocardial Ischemia|Non-alcoholic Steatohepatitis|Glucose Intolerance|Prediabetic State

Phase 2: Obesity|Marijuana Abuse|Alcoholic Intoxication|Schizophrenia|Spinal Cord Injuries|Hypertension|Affective Disorders, Psychotic|Polycystic Ovary Syndrome|Psychotic Disorders|Tobacco Use Disorder

Phase 1: Marijuana Abuse

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2022-001522-30

P3

Active, not recruiting

Spinal Cord Injuries

2024-09-29

RIMOFATSCI-2

P2

Not yet recruiting

Spinal Cord Injuries

2023-11-01

RIMOFATSCI-1

P2

Completed

Spinal Cord Injuries

2022-06-07

Effec Acomplia gastric sensitivity

P4

Completed

Healthy Volunteers

2021-03-03

Recent News Events